RVTY Profile
Revvity, Inc., headquartered in Waltham, Massachusetts, is a global leader in providing innovative products, services, and solutions to diverse markets including diagnostics, life sciences, and applied services. Originally founded in 1937 and previously known as PerkinElmer, Inc., the company rebranded to Revvity, Inc. in April 2023. Revvity operates through two key segments: Discovery & Analytical Solutions and Diagnostics, each catering to distinct yet interconnected industries.
The Discovery & Analytical Solutions segment focuses on delivering cutting-edge instruments, reagents, informatics, and software that empower scientists worldwide to drive breakthroughs in life sciences research. This includes advanced technologies for detection and imaging, as well as contract research and laboratory services. Additionally, Revvity provides analytical solutions for environmental monitoring in areas such as air, water, and soil quality assessment, supporting sustainable practices across various sectors including agriculture and industrial manufacturing.
In the Diagnostics segment, Revvity specializes in developing and supplying instruments, reagents, and assay platforms crucial for early disease detection and genetic screening. Its products are integral in diagnosing genetic disorders like down syndrome, hypothyroidism, and muscular dystrophy, as well as in infectious disease testing. The segment also pioneers genomic workflows utilizing advanced sequencing technologies for applications in oncology, immunodiagnostics, and drug discovery, serving a wide array of clients including pharmaceutical companies, research institutions, healthcare providers, and government agencies. Through its commitment to innovation and comprehensive solutions, Revvity continues to drive advancements in healthcare and environmental sciences globally.
|
